Interplay between MTOR and GPX4 signaling modulates autophagy-dependent ferroptotic cancer cell death

Yang Liu1, Yuan Wang1, Jiao Liu1

  • 1The Third Affiliated Hospital, Guangzhou Medical University, 510510, Guangzhou, Guangdong, China.

Cancer Gene Therapy
|May 28, 2020
PubMed

Insights

Mechanistic target of rapamycin kinase (MTOR) and glutathione peroxidase 4 (GPX4) signals regulate autophagy-dependent ferroptosis in pancreatic cancer. GPX4 depletion enhances anticancer drug efficacy, suggesting new therapeutic strategies.

Area of Science:

  • Cell biology
  • Molecular oncology
  • Cancer therapy

Background:

  • Ferroptosis is a key cell death pathway with potential in cancer treatment.
  • The molecular mechanisms linking autophagy and ferroptosis are not fully understood.

Purpose of the Study:

  • To investigate the role of mechanistic target of rapamycin kinase (MTOR) and glutathione peroxidase 4 (GPX4) in autophagy-dependent ferroptosis.
  • To explore the therapeutic potential of targeting this pathway in human pancreatic cancer.

Main Methods:

  • Utilized rapamycin (autophagy inducer) and RSL3 (ferroptosis activator) in human pancreatic cancer cells.
  • Investigated the effects of these agents on MTOR activation and GPX4 protein levels.
  • Employed RNA interference (RNAi) to deplete GPX4.
  • Assessed the impact of GPX4 depletion on drug efficacy in vitro and in vivo.

Main Results:

  • Both rapamycin and RSL3 inhibited MTOR activation and induced GPX4 degradation.
  • GPX4 was essential in suppressing autophagy-dependent ferroptosis induced by rapamycin and RSL3.
  • GPX4 depletion significantly enhanced the anticancer effects of rapamycin and RSL3.

Conclusions:

  • The interplay between MTOR and GPX4 signaling modulates autophagy-dependent ferroptosis in pancreatic cancer.
  • Targeting GPX4 could enhance the efficacy of existing anticancer therapies.
  • These findings offer novel therapeutic strategies for autophagy-dependent cell death in cancer treatment.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.2K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
9.0K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.5K